Tillomed Laboratories choose Mawdsleys as their distributor to hospitals
Tillomed Laboratories choose Mawdsleys as their distributor to hospitals 18th September 2017

Mawdsleys are delighted to be assisting Tillomed Laboratories in bringing their injectable products to market (September 2017). We will be distributing CMU contracted products to English hospitals and products with special prices to Scotland, Wales and Northern Ireland:

 

 

Description: Carmustine Injection Vial 100mg

Pack: 100mg

PIP Code: 7936438

EAN Code: 008902319061371

Description: Cidofovir Solution / Injection 375mg/5ml

Pack: 375mg/5ml

PIP Code: 6904312

EAN Code: 008902319061494

Description: Melphalan Injection Vial 50mg

Pack: 50mg

PIP Code: 7921141

EAN Code: 008902319061050

 

Tillomed Laboratories say about the new distribution agreement, “We are pleased to be working alongside Mawdsleys who are acknowledged as a market leader in hospital distribution, and we look forward to strengthening our partnership over the forthcoming years with new launches.”

 

With Mawdsleys you will benefit from:

 

– Industry-leading 22 days average stock holding

– EDI or online ordering

– Live stock levels, prices and invoices, as well as managing back orders, online

– No minimum order levels

– Reliable and accurate daily deliveries from your local depot

– Working together to make efficiency savings

 

Stock is available now (September 2017). Order from Mawdsleys through your normal preferred route i.e. EDI, through the Mawdsleys online ordering system, Mawdsleys Online, or by calling or faxing Customer Services.

 

Tillomed Laboratories product information is available by emailing medinfo@tillomed.co.uk

 

Should you have any queries, please contact your Mawdsleys Regional Hospital Account Manager. You may also contact Mawdsleys customer service on 0844 736 9016 or email info@mawdsleys.co.uk

 

Other latest news
https://www.mawdsleys.co.uk/news/mawdsleys-announces-new-solus-deal-with-ma-pharmachem/ thumbnail image Mawdsleys announces new solus deal with M&A Pharmachem

Mawdsleys is delighted to announce a new solus hospital distribution agreement with M&A Pharmachem.   From 1st July 2014, Mawdsleys  will become the sole distributor for all M&A Pharmachem contracted products into the hospital sector, which previously hospitals purchased from M&A directly.   As from this date, all orders for M&A products…

Read more
https://www.mawdsleys.co.uk/news/our-portfolio-is-expanding/ thumbnail image Our portfolio is expanding

  As from 1st June we are distributing products to hospitals on behalf of Hikma Pharmaceuticals, adding to our growing portfolio of products and manufacturers.   If you are a manufacturer or hospital and want to know more about how Mawdsleys can support and work with you, contact us today…

Read more